A multinational pharmaceutical organisation required assistance in developing, optimising and validation of their assay in preparation for phase III clinical trial. In addition, they required a comprehensive characterisation package for the product to provide greater insight into the vaccine and its mechanism of action that can be used in understanding product Critical Quality Attributes (CQAs).
Click here to read the client’s comments about GRA.
Complete your details and we’ll send you regular updates via our newsletter.
Need to understand some element of the biopharma industry or looking for a particular template?
© 2023 GreyRigge Associates Limited. All rights reserved.
Site design & build by Hinge Ltd.